Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Susanna Proudman(Royal Adelaide Hospital), Joanna Pepke‐Żaba(Papworth Hospital NHS Foundation Trust), George Giannakoulas(AHEPA University Hospital), Luciano Melatini, Tobias Lange(Universität Hamburg), Iveta Šimková(Slovak Medical University), David Langleben(Jewish General Hospital), Nathan Dwyer, Marius M. Hoeper(Medizinische Hochschule Hannover), Silvia Ulrich(University of Zurich), Sabino Deleo, Christian Meier(University Hospital of Basel), David Pittrow(TU Dresden), Hubert Wirtz(Coral Reef Alliance), Wendy Stevens(St Vincent's Hospital Melbourne), Jens Klotsche(German Rheumatism Research Centre), Graciela Tuhay, Norberto Vulcano, Jean‐Luc Vachiéry(Erasmus Hospital), Michael Halank(University Hospital Carl Gustav Carus), Pavel Jansa(General University Hospital in Prague), María L. Talavera, Stephan Rosenkranz(University of Cologne), Martín Bosio, John Feenstra, Henning Gall(German Center for Lung Research), Regina Steringer‐Mascherbauer(University of Chicago), Mirta Díez(Copenhagen University Hospital), Heath Adams, Jorge Cáneva, Iraklis Tsangaris(National and Kapodistrian University of Athens), Marion Delcroix(American Institute of Biological Sciences), Lorena Maldonado, Pilar Escribano Subías(Universidad Complutense de Madrid), Anne Keogh, Hans Klose(University Medical Center Hamburg-Eppendorf), Douglas Helmersen(Alberta Health Services), Marc Humbert(Inserm), Ekkehard Grünig(Heidelberg University), Eugene Kotlyar, Anco Boonstra(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gérald Simonneau(Inserm), Adriana Acosta, Peter Steele, Repke J. Snijder(St. Antonius Ziekenhuis), Joan Albert Barberà(Centre for Biomedical Network Research on Rare Diseases), Lisa Mielniczuk(University of Ottawa)
Cited by 35
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k